Posts Feed
Comments Feed

Some Anemia Treatment Agents Increase Risk Of Blood Clots And Death In Cancer Patients

Using erythropoiesis-stimulating agents (ESAs) in thetreatment of anemia increases the risk of venous thromboembolism (VTE)and death among cancer patients, according to an article in theFebruary 27, 2008 issue of JAMA.ESAs are a class of drugs that promote red blood cell production in thebody. The ESAs erythropoietin and darbepoetin are commonlyused in patients with cancer to treat anemia.

More: continued here

No Comments »

Trackback URI | Comments RSS

Leave a Reply

You must be logged in to post a comment.